{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:16:16Z","timestamp":1790396176170,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1097\/pas.0b013e3181e02f45","type":"journal-article","created":{"date-parts":[[2010,5,20]],"date-time":"2010-05-20T02:37:37Z","timestamp":1274323057000},"page":"956-964","source":"Crossref","is-referenced-by-count":86,"title":["Triple Negative Breast Cancer: Outcome Correlation With Immunohistochemical Detection of Basal Markers"],"prefix":"10.1097","volume":"34","author":[{"given":"Aye Aye","family":"Thike","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jabed","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poh Yian","family":"Cheok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Phek Yoon","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary Man-Kit","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benita","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan Soon","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puay Hoon","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210131","first-page":"155","article-title":"Prognostic and predictive factors in breast cancer by immunohistochemical analysis","volume":"11","author":"Allred","year":"1998","journal-title":"Mod Pathol"},{"key":"R2-6-20210131","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H","article-title":"Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases","volume":"63","author":"Carter","year":"1989","journal-title":"Cancer"},{"key":"R3-6-20210131","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","article-title":"Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype","volume":"14","author":"Cheang","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R4-6-20210131","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/bjc.1996.236","article-title":"Immunohistochemical expression of the c-kit proto-oncogene product in human malignant and non-malignant breast tissues","volume":"73","author":"Chui","year":"1996","journal-title":"Br J Cancer"},{"key":"R5-6-20210131","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R6-6-20210131","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10549-008-0086-2","article-title":"Pattern of metastatic spread in triple-negative breast cancer","volume":"115","author":"Dent","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"R7-6-20210131","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1158\/0008-5472.CAN-03-2970","article-title":"The prognostic implication of the basal-like (cyclin E high\/p27 low\/p53+\/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer","volume":"64","author":"Foulkes","year":"2004","journal-title":"Cancer Res"},{"key":"R8-6-20210131","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/bcr1636","article-title":"Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival","volume":"9","author":"Fulford","year":"2007","journal-title":"Breast Cancer Res"},{"key":"R9-6-20210131","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01840834","article-title":"The Nottingham Prognostic Index in primary breast cancer","volume":"22","author":"Galea","year":"1992","journal-title":"Breast Cancer Res Treat"},{"key":"R10-6-20210131","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/annonc\/mdp492","article-title":"Triple-negative breast cancer--current status and future directions","volume":"20","author":"Gluz","year":"2009","journal-title":"Ann Oncol"},{"key":"R11-6-20210131","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/bcr1041","article-title":"Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer","volume":"7","author":"Gusterson","year":"2005","journal-title":"Breast Cancer Res"},{"key":"R12-6-20210131","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1200\/JCO.2006.06.5664","article-title":"Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer","volume":"24","author":"Haffty","year":"2006","journal-title":"J Clin Oncol"},{"key":"R13-6-20210131","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ncponc0375","article-title":"Individualization of neoadjuvant therapy for breast cancer according to molecular tumor characteristics","volume":"2","author":"Hennessy","year":"2005","journal-title":"Nat Clin Pract Oncol"},{"key":"R14-6-20210131","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/01.pas.0000213306.05811.b9","article-title":"Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5\/6, and overexpress HER2 or EGFR","volume":"30","author":"Hicks","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R15-6-20210131","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota","year":"1998","journal-title":"Science"},{"key":"R16-6-20210131","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1200\/JCO.2006.10.3523","article-title":"Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system","volume":"25","author":"Hudis","year":"2007","journal-title":"J Clin Oncol"},{"key":"R17-6-20210131","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10549-007-9796-0","article-title":"alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer","volume":"111","author":"Ivanov","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"R18-6-20210131","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1524-4741.2009.00789.x","article-title":"T1N0 triple negative breast cancer: risk of recurrence and adjuvant chemotherapy","volume":"15","author":"Kaplan","year":"2009","journal-title":"Breast J"},{"key":"R19-6-20210131","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.clon.2007.09.010","article-title":"\u201cTriple negative\u201d breast cancer: a new area for phase III breast cancer clinical trials","volume":"20","author":"Kilburn","year":"2008","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R20-6-20210131","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1158\/1078-0432.CCR-06-0353","article-title":"Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer","volume":"12","author":"Laakso","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R21-6-20210131","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/cncr.23930","article-title":"Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases","volume":"113","author":"Lin","year":"2008","journal-title":"Cancer"},{"key":"R22-6-20210131","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/modpathol.3800528","article-title":"Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma","volume":"19","author":"Livasy","year":"2006","journal-title":"Mod Pathol"},{"key":"R23-6-20210131","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clon.2007.10.002","article-title":"The influence of basal phenotype on the metastatic pattern of breast cancer","volume":"20","author":"Luck","year":"2008","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R24-6-20210131","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/ijc.2910520508","article-title":"Breast cancer is associated with loss of the c-kit oncogene product","volume":"52","author":"Natali","year":"1992","journal-title":"Int J Cancer"},{"key":"R25-6-20210131","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","article-title":"Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma","volume":"10","author":"Nielsen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R26-6-20210131","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/jcp.2008.061358","article-title":"Triple negative breast cancer: a study from the point of view of basal CK5\/6 and HER-1","volume":"62","author":"Pintens","year":"2009","journal-title":"J Clin Pathol"},{"key":"R27-6-20210131","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/00313020802563510","article-title":"Triple-negative\/basal-like breast cancer: review","volume":"41","author":"Rakha","year":"2009","journal-title":"Pathology"},{"key":"R28-6-20210131","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.22381","article-title":"Prognostic markers in triple-negative breast cancer","volume":"109","author":"Rakha","year":"2007","journal-title":"Cancer"},{"key":"R30-6-20210131","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1365-2559.2007.02889.x","article-title":"Triple negative tumours: a critical review","volume":"52","author":"Reis-Filho","year":"2008","journal-title":"Histopathology"},{"key":"R31-6-20210131","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1078-0432.CCR-05-2281","article-title":"Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas","volume":"12","author":"Rodriguez-Pinilla","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R32-6-20210131","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1056\/NEJMicm063760","article-title":"Images in clinical medicine. Rapid progression of basal-type breast cancer","volume":"356","author":"Seewaldt","year":"2007","journal-title":"N Engl J Med"},{"key":"R33-6-20210131","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Sorlie","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R34-6-20210131","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression data sets","volume":"100","author":"Sorlie","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R35-6-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/00313020123290","article-title":"Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parameters","volume":"33","author":"Thike","year":"2001","journal-title":"Pathology"},{"key":"R36-6-20210131","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/modpathol.2009.145","article-title":"Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer","volume":"23","author":"Thike","year":"2010","journal-title":"Mod Pathol"},{"key":"R37-6-20210131","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2407-7-134","article-title":"Use of immunohistochemical markers can refine prognosis in triple negative breast cancer","volume":"7","author":"Tischkowitz","year":"2007","journal-title":"BMC Cancer"},{"key":"R38-6-20210131","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1038\/sj.onc.1210885","article-title":"The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1\/BRCA2-deficient and ER\/PR\/ERBB2-triple-negative breast cancer","volume":"27","author":"Tommiska","year":"2008","journal-title":"Oncogene"},{"key":"R39-6-20210131","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10549-008-0206-z","article-title":"Invasive ductal carcinoma of the breast with the \u201ctriple-negative\u201d phenotype: prognostic implications of EGFR immunoreactivity","volume":"116","author":"Viale","year":"2009","journal-title":"Breast Cancer Res Treat"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0b013e3181e02f45","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:21:40Z","timestamp":1786040500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000478-201007000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0b013e3181e02f45","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}